Individualizing Pazopanib Therapy by exploRing the Role of Early Metabolic responsE and Drug Exposure as a preDICTor for Treatment Outcome in Patients With STS
Phase of Trial: Phase IV
Latest Information Update: 06 Jun 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Pharmacodynamics; Pharmacokinetics; Therapeutic Use
- Acronyms PREDICT
- 04 Dec 2013 New trial record
- 30 Nov 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2013-003533-16).
- 21 Nov 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.